Literature DB >> 30310446

Role of the Thyroid System in the Dynamic Complex Network of Cardioprotection.

Alessandro Pingitore1, Giorgio Iervasi1, Francesca Forini1.   

Abstract

Cardioprotection is a common goal of new therapeutic strategies in patients with coronary artery disease and/or left ventricular dysfunction. Myocardial damage following ischaemia/reperfusion injury lead to left ventricular adverse remodelling through many mechanisms arising from different cell types in different myocardial districts, namely the border and remote zone. Cardioprotection must face this complex, dynamic network of cooperating units. In this scenario, thyroid hormones can represent an effective therapeutic strategy due to the numerous actions and regulating mechanisms carried out at the level of the myocytes, interstitium and the vasculature, as well as to the activation of different pro-survival intracellular pathways involved in cardioprotection.

Entities:  

Keywords:  Cardioprotection; acute myocardial infarction; heart failure; hypothyroidism; left ventricular remodelling; low T3 syndrome; thyroid hormone

Year:  2016        PMID: 30310446      PMCID: PMC6159410          DOI: 10.15420/ecr.2016:9:2

Source DB:  PubMed          Journal:  Eur Cardiol        ISSN: 1758-3756


  92 in total

Review 1.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

2.  Thyroid hormone receptors alpha1 and beta1 are downregulated in the post-infarcted rat heart: consequences on the response to ischaemia-reperfusion.

Authors:  C Pantos; I Mourouzis; T Saranteas; I Paizis; C Xinaris; V Malliopoulou; D V Cokkinos
Journal:  Basic Res Cardiol       Date:  2005-09       Impact factor: 17.165

3.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

Authors:  M S Finkel; C V Oddis; T D Jacob; S C Watkins; B G Hattler; R L Simmons
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

Review 4.  Biochemical basis of thyroid hormone action in the heart.

Authors:  W H Dillmann
Journal:  Am J Med       Date:  1990-06       Impact factor: 4.965

5.  Thyroid hormone receptor alpha 1: a switch to cardiac cell "metamorphosis"?

Authors:  C Pantos; C Xinaris; I Mourouzis; P Perimenis; E Politi; D Spanou; D V Cokkinos
Journal:  J Physiol Pharmacol       Date:  2008-06       Impact factor: 3.011

6.  Regulation of arteriolar density in adult myocardium during low thyroid conditions.

Authors:  Yingheng Liu; Benjamin A Sherer; Rebecca A Redetzke; A Martin Gerdes
Journal:  Vascul Pharmacol       Date:  2009-10-20       Impact factor: 5.773

7.  Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes.

Authors:  Faquan Liang; Paul Webb; Adhirai Marimuthu; Sumei Zhang; David G Gardner
Journal:  J Biol Chem       Date:  2003-01-30       Impact factor: 5.157

8.  Thyroid hormone replacement therapy attenuates atrial remodeling and reduces atrial fibrillation inducibility in a rat myocardial infarction-heart failure model.

Authors:  Youhua Zhang; Eduard I Dedkov; Bianca Lee; Ying Li; Khusbu Pun; A Martin Gerdes
Journal:  J Card Fail       Date:  2014-11-25       Impact factor: 5.712

9.  Thyroid hormone promotes remodeling of coronary resistance vessels.

Authors:  Olga V Savinova; Yingheng Liu; Garth A Aasen; Kai Mao; Nathan Y Weltman; Brett L Nedich; Qiangrong Liang; A Martin Gerdes
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

10.  Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes.

Authors:  D B Zorov; C R Filburn; L O Klotz; J L Zweier; S J Sollott
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  2 in total

1.  Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes.

Authors:  Helmut Raphael Lieder; Felix Braczko; Nilgün Gedik; Merlin Stroetges; Gerd Heusch; Petra Kleinbongard
Journal:  Basic Res Cardiol       Date:  2021-04-19       Impact factor: 17.165

2.  Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult.

Authors:  Ozlem Ozen Karakus; Noureldien H E Darwish; Thangirala Sudha; Taher A Salaheldin; Kazutoshi Fujioka; Peter C Taylor Dickinson; Brian Weil; Shaker A Mousa
Journal:  Biomedicines       Date:  2021-11-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.